On April 1, 2015, an Alabama woman filed a new Zofran lawsuit on behalf of herself and her young son. The plaintiff claims that because she was prescribed Zofran during her first trimester of pregnancy, her son suffers from a number of birth defects that…
The most recent status conference concerning the Xarelto MDL, currently proceeding in the Eastern District of Louisiana, took place on April 1, 2015. The U.S. Judicial Panel on Multidistrict Litigation (JPML) established the MDL in December 2014. According to minutes from the meeting, both the…
The FDA approved the use of Xarelto (rivaroxaban) in 2011 for reducing the risk of blood clots in patients undergoing knee and hip replacement surgery, and later that same year for reducing the risk of blood clots and stroke in patients with non-valvular atrial fibrillation.…
On March 20, 2015, Tennessee resident Danny Julian filed a Xarelto wrongful death lawsuit on behalf of his father, Tommy Julien. The Plaintiff claims that his father died after using the anticoagulant drug. He names manufacturers Bayer Healthcare Pharmaceuticals, Janssen Pharmaceuticals, and parent
When manufacturers first released Xarelto on the market in 2011, they advertised it as a more convenient alternative to the leading blood-thinner, warfarin. Approved for reducing the risk of blood clots following knee or hip replacement surgery, as well as to reduce risk of stroke…
All U.S. federal Xarelto lawsuits were consolidated in one court in the Eastern District of Louisiana in December 2014. Now, plaintiffs have filed a new Xarelto class action case in Canada, seeking to gain compensation for Canadian patients who took the drug and later suffered…
On March 3, 2015, the FDA issued a drug safety communication warning men about using testosterone replacement therapy products to treat symptoms of normal aging. They also announced that they are requiring testosterone drug manufacturers to add new warnings on product labels, indicating that they…
Just how accurate are the clinical trials that are submitted to the FDA for drug approvals? According to a recent study in JAMA Internal Medicine, there may be a number of errors, or “departures from good clinical practice” in these studies. These are seldom reported…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal testosterone replacement therapy lawsuits in the Northern District of Illinois in June 2014. District Judge Matthew Kennelly was appointed to oversee the proceedings. Today, there are about 1,100 cases pending in the
On January 22, 2015, another Xarelto lawsuit was filed in St. Clair County Circuit Court. The plaintiff, Sonja Lemoins, claims that after taking Xarelto to help prevent a stroke, she suffered adverse effects. In essence, she states that her blood cannot congeal or clot in…
In June of 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal testosterone replacement therapy lawsuits into one court in the Northern District of Illinois, with U.S. District Judge Matthew Kennelly overseeing the proceedings. Currently, in preparation for bell
Is it safe for older men to take testosterone drugs even if they are not diagnosed with hypogonadism? According to many studies, it may not be, but that hasn’t stopped new clinics from distributing the medications to men who want them for lifestyle reasons. FDA…